These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20705371)

  • 21. Synthesis and properties of some aryloxyaminoalkanes.
    Marona H; Gajewczyk L; Filipek B
    Acta Pol Pharm; 1996; 53(1):47-52. PubMed ID: 8960283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Synthesis and biological activity of substituted benzyl/naphthylmethylisoquinolines and related quaternary ammonium derivatives].
    Xu GY; Peng SX; Hua WY
    Yao Xue Xue Bao; 1994; 29(2):95-106. PubMed ID: 8042518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of new benzofurane, benzopiran and furanochromone derivatives--potential antiarrhythmic and hypotensive agents.
    Jedrych Z; Borkowska G
    Pol J Pharmacol Pharm; 1983; 35(5):397-403. PubMed ID: 6664941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular activities of the new potent and long-lasting antihypertensive calcium entry blocker (+-)-3-ethyl,5-methyl,2- ([2-(formylamino)-ethyl]- thiomethyl)-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicar box ylate.
    Germini M; Passoni A; Casciarri I; Bosetti P; Piazzoni L; Cazzulani P; Gandolfi CA; Tofanetti O; Ceserani R
    Arzneimittelforschung; 1992 Jan; 42(1):1-8. PubMed ID: 1586373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide.
    Li L; Whiteman M; Guan YY; Neo KL; Cheng Y; Lee SW; Zhao Y; Baskar R; Tan CH; Moore PK
    Circulation; 2008 May; 117(18):2351-60. PubMed ID: 18443240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propranolol analog with the natural monoterpene structure as a potent antiarrhythmic drug.
    Librowski T; Filipek B; Czarnecki R; Beresewicz A; Karwatowska-Prokopczuk E
    Acta Pol Pharm; 1998; 55(3):243-7. PubMed ID: 9735705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.
    Chłoń-Rzepa G; Zmudzki P; Pawłowski M; Zygmunt M; Filipek B
    Pharmacol Rep; 2011; 63(2):476-86. PubMed ID: 21602603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
    Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
    Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
    Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
    J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
    Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
    Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
    Sapa J
    Acta Pol Pharm; 2010; 67(5):537-42. PubMed ID: 20873423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of three 1,4-dihydropyridine derivatives [OSI-1210, OSI-1211 (etaftoron), and OSI-3802] on rat liver mitochondrial bioenergetics and on the physical properties of membrane lipid bilayers: relevance to the length of the alkoxyl chain in positions 3 and 5 of the DHP ring.
    Fernandes MA; Pereira SP; Jurado AS; Custódio JB; Santos MS; Moreno AJ; Duburs G; Vicente JA
    Chem Biol Interact; 2008 Jun; 173(3):195-204. PubMed ID: 18452904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, physicochemical and preliminary pharmacological properties of N-[beta-hydroxy-gamma-(N-phenylpiperazinepropyl)]-2-pyrrolidinone.
    Malawska B; Gorczyca M; Filipek B
    Pol J Pharmacol Pharm; 1992; 44(6):561-74. PubMed ID: 1305957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and hypotensive activity of a polymeric procyanidin fraction from Pistacia lentiscus L.
    Sanz MJ; Terencio MC; Paya M
    Pharmazie; 1992 Jun; 47(6):466-7. PubMed ID: 1409845
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antiarrhythmic properties of 2-(2'-hydroxy-2')-substituted ethyl-1,2,3,4-octahydropyrrolo[1,2-a]pyrazines].
    Filippova OV; Kryzhanovskiĭ SA; Peresada VP; Likhosherstov AM; Revenko SV; Kaverina NV; Reznikov KM
    Eksp Klin Farmakol; 2004; 67(4):26-9. PubMed ID: 15500041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorenone 1,4-dihydropyridine derivatives with cardiodepressant activity: enantiomeric separation by chiral HPLC and conformational aspects.
    Caccamese S; Chillemi R; Principato G
    Chirality; 1996; 8(3):281-90. PubMed ID: 8777149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of thyroid hormone uptake by calcium antagonists of the dihydropyridine class.
    Scholz GH; Vieweg S; Uhlig M; Thormann M; Klossek P; Goldmann S; Hofmann HJ
    J Med Chem; 1997 May; 40(10):1530-8. PubMed ID: 9154974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
    Orallo F; Calleja JM; García Mera G; Raviña E
    Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.